Atrial fibrillation is the most common heart arrhythmia with a prevalence of approximately 2% in the western world. Atrial fibrillation is associated with an increased risk of death and morbidity. The comparable effects of a lenient rate control strategy and a strict rate control strategy in patients with atrial fibrillation are uncertain and only one trial has assessed this previously in patients with permanent atrial fibrillation. The investigators will therefore undertake a randomised, superiority trial at four hospitals in Denmark.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
350
Treatment will be provided according to current guidelines and as such the algorithm for treatment will be differentiated based on the status of left ventricular ejection fraction. For participants with reduced left ventricular ejection fraction, beta-blockers (metoprolol and bisoprolol) will be the primary therapy. Secondary therapies may include digoxin or amiodarone. For participants with preserved left ventricular ejection fraction, the primary therapy will be beta-blockers (metoprolol and bisoprolol) or non-dihydropyridine calcium-channel blockers (verapamil) with secondary therapy consisting of digoxin or amiodarone. Pacing therapies, alone or with atrioventricular node ablation, are utilised as indicated in the view of the treating physician.
Holbæk Hospital
Holbæk, Denmark
RECRUITINGHvidovre University Hospital
Hvidovre, Denmark
NOT_YET_RECRUITINGOdense University Hospital
Odense, Denmark
NOT_YET_RECRUITINGZealand University Hospital - Roskilde
Roskilde, Denmark
NOT_YET_RECRUITINGShort Form-36 (SF-36) physical component score
Time frame: After 1 year
Days alive outside hospital
Time frame: After 6 months
Atrial Fibrillation Effect on Quality of Life (AFEQT)
Time frame: After 1 year
Short Form-36 (SF-36) mental component score
Time frame: 1 year
Serious adverse events
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.